All tenders
75N93022C00061
A NOVEL LPXC INHIBITOR WITH PAN-RESISTANT PSEUDOMONAS AND BURKHOLDERIA ACTIVITY.
National Institutes of Health · United States
This contract has been awarded. Browse open opportunities
Time Left to Bid
Awarded
AwardedOtherFederal
Basic information
- Reference number
- 75N93022C00061
- Issuing organization
- National Institutes of Health · Find award history →
- Government level
- Federal
- Solicitation type
- Other
- Title
- A NOVEL LPXC INHIBITOR WITH PAN-RESISTANT PSEUDOMONAS AND BURKHOLDERIA ACTIVITY.
- Source
- USASpending (Federal)
- Source ID
- usa-75N93022C00061
Details
- Location
- United States
Description
A NOVEL LPXC INHIBITOR WITH PAN-RESISTANT PSEUDOMONAS AND BURKHOLDERIA ACTIVITY. Awarded to: REVAGENIX INC Agency: Department of Health and Human Services Sub-agency: National Institutes of Health Award type: DEFINITIVE CONTRACT
Dates
- Publication
- 2022/09/22 12:00:00 AM UTC
- Closing date
- 2028/04/25 12:00:00 AM UTC
Estimated value
$28.2M USD
Classification
Normalized category
Other